Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF‐β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection - Top-Institutions - MDSpire

Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF‐β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection

  • By

  • Su Yeon Kang

  • Jeong Rae Yoo

  • EunJin Bae

  • Joowan Kim

  • Yejin Park

  • Misun Kim

  • Miyeon Kim

  • Hyo-Jin Ro

  • Daehee Hwang

  • Jeong-Yeon Lee

  • Dongcharn Cho

  • Huy Chau Nguyen

  • Hoai Jaclyn Hallam

  • Sang Taek Heo

  • Nam-Hyuk Cho

  • Kyung-Mi Lee

  • Andrew G. Letizia

  • Keun Hwa Lee

  • June 25, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University and Health System
    Johns Hopkins University and Health System

    Baltimore, Maryland

    Key Differentiators

    • Infectious Disease

  • #2

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, New York

    Key Differentiators

    • Infectious Disease

  • #3

    University Hospital Regensburg
    University Hospital Regensburg

    Regensburg, Bavaria

    Key Differentiators

    • Infectious Disease

  • #4

    University of Regensburg
    University of Regensburg

    Regensburg, Bavaria

    Key Differentiators

    • Infectious Disease

  • #5

    Amsterdam UMC
    Amsterdam UMC

    Amsterdam, North Holland

    Key Differentiators

    • Infectious Disease

Original Source(s)

Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF‐β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection

  • by Su Yeon Kang, Jeong Rae Yoo, EunJin Bae, Joowan Kim, Yejin Park, Misun Kim, Miyeon Kim, Hyo-Jin Ro, Daehee Hwang, Jeong-Yeon Lee, Dongcharn Cho, Huy Chau Nguyen, Hoai Jaclyn Hallam, Sang Taek Heo, Nam-Hyuk Cho, Kyung-Mi Lee, Andrew G. Letizia, Keun Hwa Lee

  • June 25, 2026

Related Content

Clinical Evaluation of a Real-Time Wearable System for Monitoring In-Hospital Ambulatory Patients With COVID-19: Retrospective Data Study

Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine

COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice